|
Aug 6
|
Emergent BioSolutions Expands NARCAN® Nasal Spray Distribution Capabilities to Enhance Customer Delivery Experience Across the Country
|
|
Aug 2
|
Emergent BioSolutions (NYSE:EBS shareholders incur further losses as stock declines 23% this week, taking three-year losses to 83%
|
|
Jul 31
|
Emergent BioSolutions Completes Sale of RSDL® (Reactive Skin Decontamination Lotion) Kit to SERB Pharmaceuticals for $75 Million
|
|
Jul 25
|
The stock market’s cruel summer is about to get much worse
|
|
Jul 24
|
Emergent BioSolutions Launches Opioid Emergency Preparedness ‘Lay, Spray, Stay’ Public Education Campaign Starring Pro Football Hall of Famer Emmitt Smith
|
|
Jul 23
|
Emergent BioSolutions to Release Second Quarter 2024 Financial Results & Conduct Conference Call on August 6, 2024
|
|
Jun 21
|
Emergent to sell US sterile manufacturing facility to Bora
|
|
Jun 20
|
Emergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals for $30 Million
|
|
May 10
|
Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024
|
|
May 2
|
Q1 2024 Emergent BioSolutions Inc Earnings Call
|
|
May 2
|
Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript
|
|
May 2
|
Emergent BioSolutions Inc (EBS) (Q1 2024) Earnings Call Transcript Highlights: A Strong Start ...
|
|
May 2
|
PRESS DIGEST- Wall Street Journal - May 2
|
|
May 2
|
Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript
|
|
May 1
|
Emergent BioSolutions Reports Surprising Q1 2024 Earnings, Exceeding Revenue and Net Income ...
|
|
May 1
|
Narcan-Maker Emergent BioSolutions to Cut 300 Jobs, Close Facilities
|
|
May 1
|
Emergent BioSolutions Reports First Quarter 2024 Financial Results
|
|
May 1
|
Emergent BioSolutions to lay off about 300 employees
|
|
May 1
|
UPDATE 2-Emergent BioSolutions to lay off about 300 employees
|
|
May 1
|
Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position
|